In Re Listerine Total Care Mouthwash Marketing & Sales Practices Litigation

764 F. Supp. 2d 1354, 2011 U.S. Dist. LEXIS 12664, 2011 WL 484282
CourtUnited States Judicial Panel on Multidistrict Litigation
DecidedFebruary 9, 2011
DocketMDL No. 2210
StatusPublished

This text of 764 F. Supp. 2d 1354 (In Re Listerine Total Care Mouthwash Marketing & Sales Practices Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Listerine Total Care Mouthwash Marketing & Sales Practices Litigation, 764 F. Supp. 2d 1354, 2011 U.S. Dist. LEXIS 12664, 2011 WL 484282 (jpml 2011).

Opinion

TRANSFER ORDER

DAVID R. HANSEN, Acting Chairman.

Before the Panel: * Plaintiff in the action pending in the Southern District of Florida (Pelkey) has moved, pursuant to 28 U.S.C. § 1407, for coordinated or consolidated pretrial proceedings of this litigation in the Southern District of Florida. Defendants 1 support the motion. Plaintiff in the District of New Jersey Evoy action agrees that centralization is appropriate and supports centralization in any court in which a related action is pending. Plaintiff in the Northern District of California action (Britton) suggests centralization in the Northern District of California. Plain *1355 tiff in a potential tag-along action supports centralization in the Southern District of Florida or the District of New Jersey.

This litigation currently consists of four actions listed on Schedule A and pending in three districts, two actions in the District of New Jersey and one action each in the Northern District of California and the Southern District of Florida. 2

On the basis of the papers filed and hearing session held, we find that these actions involve common questions of fact, and that centralization under Section 1407 in the Southern District of Florida will serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. These actions share factual questions arising out of allegations that defendants’ representations regarding Listerine Total Care Anti-cavity Mouthwash (Total Care) were misleading insofar as they claimed that Total Care fights plaque above the gum line and prevents cavities. All responding parties agree that centralization is appropriate. Centralization will eliminate duplicative discovery; prevent inconsistent pretrial rulings, including with respect to class certification; and conserve the resources of the parties, their counsel, and the judiciary.

Any of the three districts in which a constituent action is pending would be a suitable transferee district. All actions were filed within a few weeks of each other and none are particularly advanced. After considering all factors, the Panel has decided to order centralization in the Southern District of Florida. Defendants and some plaintiffs support centralization in the Southern District of Florida, and this district is presiding over fewer MDL dockets than other proposed districts. Judge William P. Dimitrouleas is well-qualified to steer this litigation.

IT IS THEREFORE ORDERED that, pursuant to 28 U.S.C. § 1407, the actions listed on Schedule A and pending outside the Southern District of Florida are transferred to the Southern District of Florida and, with the consent of that court, assigned to the Honorable William P. Dimitrouleas for coordinated or consolidated pretrial proceedings with the action pending there and listed on Schedule A.

SCHEDULE A

MDL No. 2210 — IN RE: LISTERINE TOTAL CARE MOUTHWASH MARKETING AND SALES PRACTICES LITIGATION

Northern District of California

Charlene A. Britton v. Johnson & Johnson, et al., C.A. No. 3:10-04450

Southern District of Florida

Nikki Pelkey v. McNeil Consumer Healthcare, C.A. No. 0:10-61853

District of New Jersey

David Evoy v. Johnson & Johnson Healthcare Products Division of McNeilr-PPC, Inc., C.A. No. 2:10-05252

Scott J. Duca v. Johnson & Johnson, et al., C.A. No. 3:10-05292

*

Judges John G. Heyburn II and Kathryn H. Vratil took no part in the decision of this matter.

1

. McNeil-PPC, Inc., Johnson & Johnson, Johnson & Johnson Healthcare Products Division of McNeil-PPC, Inc., McNeil Consumer Healthcare, and Johnson & Johnson Consumer Products, Inc.

2

. The parties have notified the Panel that three additional related actions are pending, one action each in the Central District of California, the Northern District of California, and the District of New Hampshire. These actions are potential tag-along actions. See Rule 7.1, R.P.J.P.M.L.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Multidistrict litigation
28 U.S.C. § 1407

Cite This Page — Counsel Stack

Bluebook (online)
764 F. Supp. 2d 1354, 2011 U.S. Dist. LEXIS 12664, 2011 WL 484282, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-listerine-total-care-mouthwash-marketing-sales-practices-litigation-jpml-2011.